VA Research: COVID, substance use, Gulf War findings
The VA's Office of Research and Development has released three new research briefs covering critical health topics for veterans, including findings on COVID-19 risks for Gulf War veterans, innovative approaches to substance use disorder treatment, and the ongoing challenges faced by those living with Gulf War Illness. These studies demonstrate how VA research continues to address veteran-specific health concerns while developing more effective and accessible treatment methods.
The first study, conducted by VA researchers in West Haven, Connecticut, used the Million Veteran Program database to examine whether Gulf War veterans faced higher risks of adverse COVID-19 outcomes. The Million Veteran Program is one of the world's largest health genetics databases, allowing researchers to compare health outcomes across massive veteran populations. This particular study addressed widespread concerns among Gulf War veterans that their service-related health conditions might make them more vulnerable to severe COVID complications during the early pandemic period before vaccines became available.
The COVID-19 research compared more than 130,000 veterans and found that those who deployed overseas during the 1990-1991 Gulf War were only 1.6 percent more likely to test positive for COVID-19 and were not associated with increased COVID-related health risks overall. While researchers noted that additional studies would be needed to determine whether these findings hold true in the vaccination era, the results provide reassurance to Gulf War veterans who have been concerned about their vulnerability to the virus. This study also demonstrates how the Million Veteran Program can rapidly respond to emerging veteran health concerns using existing data.
The second research brief examined contingency management, a treatment approach that uses tangible incentives to encourage positive behaviors such as abstaining from substance use and adhering to medication schedules for substance use disorders. VA researchers adapted a hybrid telehealth model originally developed during the COVID-19 pandemic to deliver these incentive-based treatments more efficiently. The results showed that veterans in the contingency management program received 1.62 times as much medication over a year compared to the comparison group, proving that effective incentives do not need to be expensive or labor-intensive to work.
The third study, conducted by researchers at the Portland VA Medical Center, combined qualitative interview data with survey responses from 39 Gulf War veterans to better understand the daily challenges of living with Gulf War Illness. Veterans reported significant difficulties with communication, navigating VA benefits, and even having their condition recognized as a legitimate illness. Gulf War Illness encompasses persistent, unexplainable symptoms including chronic fatigue, pain, cognitive impairment, and gastrointestinal distress that have affected many veterans who served in the 1990-1991 Gulf War.
For disabled veterans, these research findings matter because they directly inform VA policy, treatment options, and benefit decisions. The Gulf War Illness study in particular highlights historical gaps in care that recent legislative and policy changes have begun to address, though the researchers emphasize the need for standardized institutional commitment and broader access to individualized treatments. Understanding how VA research translates into improved care helps veterans advocate more effectively for their own health needs.
Veterans interested in these research areas should discuss relevant findings with their VA healthcare providers, particularly if they served in the Gulf War or are receiving treatment for substance use disorders. Those experiencing unexplained chronic symptoms consistent with Gulf War Illness should ensure their conditions are properly documented in their VA medical records and consider working with a veterans service organization to explore potential service-connection claims. The full studies are available through the VA's Office of Research and Development website for veterans who want more detailed information about methodologies and findings.